The story of Viagra presents a complex case for investors in the medicinal sector. While initially a phenomenal success, generating vast sums, the intellectual property expiration and the subsequent entry of cheaper https://adult300031.gynoblog.com/40484264/sildenafil-and-big-pharma-a-speculative-investment